Benchmark Holdings plc Share Price

Equities

BMK

GB00BGHPT808

Fishing & Farming

Market Closed - London S.E. 09:05:16 26/04/2024 pm IST 5-day change 1st Jan Change
44.75 GBX -6.77% Intraday chart for Benchmark Holdings plc +2.87% +31.42%

Financials

Sales 2024 * 177M 221M 18.43B Sales 2025 * 200M 249M 20.79B Capitalization 331M 413M 34.47B
Net income 2024 * -7M -8.74M -729M Net income 2025 * 1M 1.25M 104M EV / Sales 2024 * 2.19 x
Net Debt 2024 * 57.13M 71.37M 5.95B Net Debt 2025 * 42.81M 53.47M 4.46B EV / Sales 2025 * 1.87 x
P/E ratio 2024 *
-45.5 x
P/E ratio 2025 *
40.6 x
Employees 823
Yield 2024 *
-
Yield 2025 *
-
Free-Float 71.84%
More Fundamentals * Assessed data
Dynamic Chart
1 day-6.77%
1 week+2.87%
Current month+0.67%
1 month-0.44%
3 months+5.29%
6 months+19.33%
Current year+31.42%
More quotes
1 week
43.00
Extreme 43
48.00
1 month
42.00
Extreme 42
48.00
Current year
33.30
Extreme 33.295
48.00
1 year
33.15
Extreme 33.15
48.00
3 years
33.00
Extreme 33
67.00
5 years
24.00
Extreme 24
68.00
10 years
24.00
Extreme 24
125.75
More quotes
Managers TitleAgeSince
Chief Executive Officer 61 01/20/01
Director of Finance/CFO 47 01/19/01
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Director/Board Member 47 14/19/14
Director/Board Member 49 17/23/17
Chairman 63 08/18/08
More insiders
Date Price Change Volume
26/24/26 44.75 -6.77% 143,492
25/24/25 48 +5.49% 16,995
24/24/24 45.5 -1.09% 770
23/24/23 46 +4.31% 18,774
22/24/22 44.1 +1.38% 235,394

Delayed Quote London S.E., April 26, 2024 at 09:05 pm IST

More quotes
Benchmark Holdings plc is a United Kingdom-based aquaculture biotechnology company. The Company is focused on providing specialized mission-critical solutions in three complementary areas: genetics, health and advanced nutrition. The Company’s segments include Genetics, Advanced Nutrition and Health. The Genetics segment is salmon breeding technology combined with production facilities to provide a range of genetic merit ova. The Advanced Nutrition segment manufactures and provides nutrition and health products to the global aquaculture industry. The Health segment is focused on providing health products to the global aquaculture market. The Company has a portfolio of products and solutions, including salmon eggs with specialist genetic traits, shrimp broodstock, tilapia fry, technology enhanced live feed (Artemia), specialist diets, probiotics, and sea lice treatment solutions.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
0.4475 GBP
Average target price
0.5758 GBP
Spread / Average Target
+28.67%
Consensus